Metabolic follow-up at one year and beyond of women with gestational diabetes treated with insulin and/or oral hypoglycaemic agents: study protocol for the identification of a core outcomes set using a Delphi survey

BACKGROUND: Gestational diabetes (GDM) is associated with an increased lifetime risk for the development of glucose abnormalities, metabolic syndrome, cardiovascular disease, depression and tumours. Despite this high risk of additional comorbidities, there is no standardised approach to the long-ter...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Trials
Prif Awduron: Bogdanet, Delia, Egan, Aoife, Fhelelboom, Narjes, Biesty, Linda, Thangaratinam, Shakila, Dempsey, Eugene, Crowther, Caroline, Devane, Declan, Dunne, Fidelma
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2019
Pynciau:
Study Protocol
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6321696/
https://ncbi.nlm.nih.gov/pubmed/30611300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-018-3059-8
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg